Welcome to Consumer Reports Advocacy

For 85 years CR has worked for laws and policies that put consumers first. Learn more about CR’s work with policymakers, companies, and consumers to help build a fair and just marketplace at TrustCR.org

Letter to the FDA on statins

November 16, 2007
FDA Statins Letter 11-16-07
211.7 KB

CU believes such review should involve a formal systematic analysis of existing studies
and a benefit-risk analysis targeted primarily at the “primary-prevention” population.

IssuesHealth
You Might Also Be Interested In
July 29, 2021
CR letter to Senate Judiciary Committee supporting bipartisan prescription drug antitrust bills
April 29, 2021
CR letter to House Judiciary Committee, competition in health care and pharmaceuticals
press release
December 22, 2020
Congress acts to restore competition to health insurance by removing 75-year-old antitrust exemption
December 1, 2020
Consumer Reports letter to Senate Appropriations Committee in defense of FTC Contact Lens Rule